• LAST PRICE
    0.0100
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.0100/ 134
  • Ask / Lots
    0.0150/ 2,850
  • Open / Previous Close
    0.0100 / 0.0100
  • Day Range
    Low 0.0100
    High 0.0100
  • 52 Week Range
    Low 0.0050
    High 0.0400
  • Volume
    245,200
    average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 0.01
TimeVolumeRVV
09:32 ET280000.01
09:37 ET480000.01
10:33 ET370000.01
12:15 ET500000.01
01:02 ET520000.01
01:22 ET300000.01
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaRVV
Revive Therapeutics Ltd
4.2M
-0.7x
---
CanadaAWKN
Awakn Life Sciences Corp
5.0M
-1.2x
---
CanadaRKV
Rakovina Therapeutics Inc
5.4M
-1.3x
---
CanadaGTTX
GeneTether Therapeutics Inc
3.9M
-4.7x
---
CanadaASEP
Asep Medical Holdings Inc
3.0M
-0.8x
---
CanadaCVM.H
CVR Medical Corp
2.0M
-0.6x
---
As of 2024-11-22

Company Information

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).

Contact Information

Headquarters
82 Richmond Street EastTORONTO, ON, Canada M5C 1P1
Phone
905-605-5535
Fax
905-605-5535

Executives

Executive Chairman of the Board, Chief Executive Officer
Michael Frank
Chief Financial Officer, Corporate Secretary
Carmelo Marrelli
Independent Director
Joshua Herman
Independent Director
William Jackson
Independent Director
Andrew Lindzon

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$4.2M
Revenue (TTM)
$0.00
Shares Outstanding
418.6M
Revive Therapeutics Ltd does not pay a dividend.
Beta
-0.03
EPS
$-0.01
Book Value
$0.02
P/E Ratio
-0.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.